Functional Characteristics of Reversibly Immortalized Hepatic Progenitor Cells Derived from Mouse Embryonic Liver
markers and hepatocyte-related markers. Upon dexamethasone (Dex) stimulation, the iHP cells are able to express mature hepatocyte markers and perform ICG uptake and glycogen storage functions. Cre recombinase-mediated removal of SV40 T antigen reverses the proliferative activity of the iHP cells. When the iHP cells are subcutaneously implanted in the athymic nude mice, no tumor formation is observed for up to 8 weeks. Therefore, our results demonstrate that the established iHP cells are stable, reversible, and nontumorigenic progenitor-like cells. The iHP cells should be a valuable resource for studying stem cell biology, liver organogenesis, and metabolic regulations, hepatic tumorigenesis, and identifying factors involved in directed lineage-specific differentiation for potential hepatocyte transplantation as a treatment of liver diseases.
Materials and Methods
Cell culture medium and chemicals HEK-293 and mouse hepatoma Hepa1-6 cell lines were obtained from ATCC (Manassas, VA) and maintained in complete Dulbecco's modified Eagle's medium (DMEM) as described [42] [43] [44] [45] . For hepatic differentiation induction, cells were treated with complete medium containing 0.1μmol/L dexamethasone (Dex) as described [46, 47] . Unless indicated otherwise, all chemicals were purchased from Sigma-Aldrich (St. Louis, MO, USA).
Isolation of hepatic progenitor cells from mouse embryonic liver tissues
The animal welfare, use, and care were carried out according to the approved protocol by the Institutional Animal Care and Use Committee. Post coitus day 11.5 to 14.5 mouse embryos from the timed pregnant CD1 female mice were obtained from The University of Chicago Transgenic Core Facility for isolating primary fetal hepatic progenitor cells as described [46] [47] [48] . Briefly, the fetal liver tissues were dissected out, rinsed with cold sterile PBS, and minced into pieces smaller than 1.0 mm 3 , followed by incubation in 0.25% trypsin/1mM EDTA with gentle agitations at 37°C for 10~15min. Then, 10ml of complete DMEM were added to inactivate trypsin, and the digested cell/tissue mixture was filtered through 100μm strainers to remove cell/tissue debris. Recovered cells were seeded on 100mm cell culture dishes pre-coated with type I collagen and incubated at 37°C and 5% CO 2 . After 24h, medium was changed and non-adherent cells were removed. When reaching approximately 90% confluence, the isolated primary cells were passaged for making stable cell lines.
Establishment of stable embryonic hepatic progenitor cell lines
The retroviral vector SSR#69 expressing SV40 large T antigen flanked with LoxP sites and pCLAmpho packaging vector were co-transfected into HEK-293 cells to produce packaged retrovirus as described [49] [50] [51] [52] [53] [54] . Subconfluent primary fetal liver cells isolated above were infected with retrovirus and selected with hygromycin B (0.3mg/mL, Invitrogen) for 7~10 days. The stable cells were collected by trypsinization, serially diluted, and plated in 96-well cell culture plates using limiting dilution cloning method. Clones derived from single cells were selected and scaled up for further characterization while clone stocks were kept in liquid nitrogen tanks. Clones were designated as immortalized hepatic progenitors (iHP) and distinguished by their embryonic stages. For example, iHP13 clones indicate those immortalized clones that were derived from the hepatic progenitors obtained from E13.5 liver tissues.
As a control line for mature hepatocytes, the primary hepatocytes were isolated from 14-day-old CD1 mouse liver tissues and immortalized in a similar fashion as described above. The resultant stable cells were designated as LC14d. Mouse hepatoma Hepa1-6 line was also used as a control.
Recombinant adenoviruses expressing Cre recombinase (Ad-Cre), firefly luciferase (Ad-FLuc), and green fluorescent protein (Ad-GFP)
Recombinant adenoviruses were generated using the AdEasy technology [55, 56] . The coding regions of Cre recombinase and firefly luciferase (FLuc) were PCR amplified and subcloned into an adenoviral shuttle vector and subsequently used to generate recombinant adenoviruses in our recently engineered packaging line 293pTP [57] , resulting in adenoviruses Ad-Cre and Ad-FLuc, which also express GFP as a marker for monitoring infection efficiency. Analogous adenovirus only expressing GFP (Ad-GFP) was used as a control [44, [58] [59] [60] [61] [62] [63] [64] [65] [66] . For all adenovirus infections, polybrene (8µg/ml) was added to the culture medium in order to enhance transgene transduction efficiency [67] .
RNA isolation, quantitative and semi-quantitative RT-PCR (qPCR and sqPCR) analyses
Freshly prepared mouse liver tissues at the indicated development stages were dissected out, rinsed with PBS, minced, and then homogenized in the TRIzol reagent (Invitrogen). For the cultured cells, subconfluent cells were seeded in 60mm dishes in a complete DMEM with different treatments. Total RNA was extracted using the TRIzol reagent according to the manufacturer's instructions. The cDNA synthesis was carried out using hexamer and Superscript II Reverse Transcriptase RT (Invitrogen). The cDNA products were diluted 10-to 100-fold and used as PCR templates. 18~20 mers of primers were designed with the Primer3.0 program to amplify the genes of interest (Table 1) . PCR products were approximately 100~150 bps. SYBR Green-based qPCR analysis was carried out by using the thermocycler Opticon II DNA Engine (Bio-Rad, CA) with a standard pUC19 plasmid as described elsewhere [48, 54] . The qPCR reactions were done in triplicate. The sqPCR was also carried out as described [58, 63, 68, 69] . Briefly, sqPCR reactions were carried out by using a touchdown protocol: 94°C × 20'', 68°C × 30'', 70°C× 20'' for 12 cycles, with 1°C decrease per cycle, followed by 25-30 cycles at 94°C× 20'', 56°C × 30'', 70°C × 20''. PCR products were resolved on 1.5% agarose gels. All samples were normalized by the expression level of GAPDH.
Indocyanine Green (ICG) uptake and release assay
The ICG uptake and release assay was carried out as described [46, 47, 70] . Subconfluent iHP cells were plated in 24-well culture plates and treated with Dex (0.1 μM) or DMSO for 10 days. Cells were washed with PBS and incubated with ICG (1mg/mL in complete DMEM) at 37°C for 1h, followed by PBS washes. ICG uptake was observed and recorded under a bright field microscope. For ICG release detection, the ICGcontaining medium was changed with regular complete medium, and the cells were incubated for additional 6h. Stained cells were again observed under a microscope. Each assay condition was done in triplicate. 
SV40 T antigen Western blotting analysis
Western blotting was carried out as described [71] [72] [73] . Briefly, the iHP lines and control Hepa1-6 cells were seeded in 60mm cell culture dishes and infected with Ad-Cre or Ad-GFP. At 48h post infection, total cellular proteins were extracted with the RIPA Lysis Buffer (25mM Tris-HCl pH 7.6, 150mM NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS) and subjected to 8% SDS-PAGE. The resolved proteins were electrically transferred to Immobilon-P membranes (Millipore). The membranes were blocked with SuperBlock Blocking Buffer (Pierce, Rockford, IL) at room temperature for 1hr, followed by incubation with anti-SV40 T antigen or anti-β-actin antibody (Santa Cruz Biotechnology) at 4°C overnight, and probed with appropriate secondary antibodies conjugated with horseradish peroxidase (Santa Cruz Biotechnology) at room temperature for 1h. The presence of the proteins was visualized by using the SuperSignal West Pico Chemiluminescent Substrate kit (Pierce) with the Kodak 440CF Image Station.
Cell viability Trypan Blue staining assay
Cell viability was measured using the Trypan blue exclusion assay as described [8, 61, 74] . Briefly, subconflucent iHP lines and Hepa1-6 cells were seeded in 24-well culture plates and infected with AdCre or Ad-GFP. The infected cells were collected at the indicated time points and mixed with Trypan Blue buffer (final concentration at 0.1% Trypan blue). Viable cells of the stained cell mixtures were subjected to hemocytometer cell counting under a microscope. Each assay condition was done in triplicate.
Albumin promoter-driven Gaussia luciferase (Alb-GLuc) reporter assay
The homemade pSEB-Alb-GLuc reporter contains the mouse 2.5-kb albumin promoter sequence that drives the expression of Gaussia luciferase [46] [47] [48] . Subconfluent iHP14-19 cells were seeded in 24-well culture plates, transfected with pSEB-Alb-GLuc plasmid using LipofectAmine reagent (Invitrogen), infected with Ad-Cre or Ad-GFP, and treated with Dex (0.1 μM) or DMSO for 10 days. At the indicated time points, culture medium was collected for Gaussia luciferase assays using the Gaussia Luciferase Assay Kit (New England Biolabs). All assays were performed in triplicate.
In vivo cell implantation and Xenogen bioluminescence imaging
The use and care of animals was approved by the Institutional Animal Care and Use Committee. Subconfluent iHP lines and Hepa1-6 cells were co-infected with Ad-FLuc and Ad-Cre or Ad-GFP for 24h. The infected cells (5×10 6 cells/injection) were collected and injected subcutaneously into the flanks of athymic nude mice (male, 4-6 wk old, Harlem Research Laboratory; 5 animals/group). At 1 day, 1 week and 2 weeks after implantation, the animals were subjected to bioluminescence imaging using Xenogen IVIS 200 imaging system as described [50, 61, 63, 73, 75, 76] . Mice were injected (i.p.) with D-Luciferin sodium salt (Gold BioTechnology) at 100 mg/kg in 0.1ml PBS. The pseudo images were obtained by superimposing the emitted light over the gray-scale photographs of the mice. Quantitative analysis was done with Xenogen's Living Image software.
Statistical analysis
All quantitative data were presented as mean ± SD. The two-tailed student's t test was used for statistical analysis. In all assays, the probability value (p) of <0.05 was considered statistically significant. Error bars represent the SD of three independent experiments.
Results

Endogenous expression of hepatic progenitor and liver-related genes at different stages of mouse liver development
In order to isolate primary hepatic progenitor cells form liver tissue, we firstly sought to examine the expression profiles of hepatic progenitor and related markers in liver tissues derived from different stages of liver development from post coitus day 12.5 to postnatal 4 weeks. We carried out qPCR analysis of the expression of endothelial and progenitor markers CD34 and Pou5f1/Oct4, hepatic markers AFP, Dlk, and Alb, and mature hepatocyte markers CK18, TAT, and ApoB. We found that early hepatic stem cell marker CD34 [77] and somatic stemness-related marker POU domain, class 5, transcription factor 1 (Pou5f1/ Oct4) [78] highly expressed in prenatal liver tissues and decreased quickly after birth ( Fig.  1A and 1B ). The expression of hepatic early marker genes delta-like protein-like protein (Dlk) and alpha-fetaprotein (AFP) [79, 80] was readily detected in early liver tissues and increased to top expression at post coitus day 16.5 and postnatal day 1, respectively, then significantly decreased in postnatal liver tissues and became undetectable in postnatal 28 Endogenous expression of hepatic progenitor and liver-related genes at different stages of mouse liver development. Total RNA was isolated from mouse liver tissues at the indicated 8 time points. The qPCR was carried out to detect the expression of endothelial progenitor cell markers CD34 (A) and Pou5f1/Oct4 (B), hepatic markers AFP (C), Dlk (D), and Alb (E), and mature hepatocyte markers CK18 (F), TAT (G), and ApoB (H). All samples were normalized with GAPDH and done in triplicate. Relative expression was calculated by dividing the qPCR value of a given gene of interested with its respective GAPDH value.
Bi et al.: Characterization of Immortalized Hepatic Progenitors
Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry days ( Fig. 1C and 1D ). Alb and cytokeratin 18 (CK18) are considered hepatic specific markers, while tyrosine amino transferase (TAT) and apoplipoprotein B (ApoB) are synthesized by functional hepatocytes [81, 82] . These four markers had low-or nonexpression in embryonic liver tissues, but increased quickly after birth and maintained at a relatively high expression level ( Fig. 1E  to 1H ). Thus, our results suggest that the most of hepatic progenitor cells may be present in the stage prior to post coitus day 14.5.
Endogenous expression of hepatic/pancreatic transcription factors during mouse liver development
Hepatocyte nuclear factors (HNFs) are a group of phylogenetically unrelated transcription factors that regulate the transcription of a diverse group of genes, including certain genes that are important for hepatic functions, such as morphological and functional differentiation of hepatocytes, glucose transport and metabolism [83] . Among the HNFs, HNF3α/Foxa1, HNF3β/Foxa2, and HNF4α/MODY1 have been shown to play essential roles in hepatic/pancreatic/intestine development [84] . We sought to examine the expression patterns of HNF3α/Foxa1, HNF3β/Foxa2, and HNF4α/MODY1 during liver development. We found that although all three genes' expression levels varied, HNF3α and HNF3β exhibited rather steady prenatal expression level with a postnatal spike at D7 to D14 ( Fig. 2A  and 2B ) while HNF4α/MODY1 expressed progressively higher and peaked at D14 (Fig. 2C) . Interestingly, HNF4α/MODY1 exhibited much higher expression than that of the HNF3α/ Foxa1 and HNF3β/Foxa2's at each tested time ( Fig. 2A and 2B vs. 2C), suggesting that HNF4α/ MODY1 may be more abundant and play important liver-specific roles. Taken together, these results indicate that embryonic liver tissues may serve as a good source of hepatic progenitor cells that are programmed for liver-specific gene expression and differentiation.
Establishment of reversibly immortalized hepatic progenitor (iHP) cell clones from mouse fetal liver
As mouse fetal liver can't be easily identified until post coitus day 10.5, we prepared and isolated primary HP cells from mouse embryonic liver tissues of post coitus day 11.5 to 14.5. The freshly isolated primary cells could be maintained in complete DMEM culture for up to two weeks (Fig. 3A) . To generate reversibly immortalized progenitor cells, we used the immortalizing retroviral SSR#69 vector that expresses a hygromycin-resistance gene (Fig. 3B ) [49] . We have successfully used this system and immortalized primary progenitors from various sources [50-52, 54, 62] . Accordingly, we successfully generated immortalized hepatic progenitor (iHP) cells isolated from different stages of embryonic liver tissues (Fig. 3C) . Unlike primary HP cells, the iHP cells can be passaged and stable in culture for numerous generations. Thus, we demonstrate that SV40 T antigen mediated-immortalization strategy is effective to establish long-term cell culture of hepatic progenitor cells.
Characterization of individual iHP clones
As hepatic progenitor cells isolated from fetal liver tissues may contain various types of cells, such as hepatocytes, parenchymal cells, stellate cells, kupffer cells, and liver fibroblasts, we performed the limiting dilution cloning assays and identified more than 60 clones that were derived from single iHP cells. Thirty-two clones were randomly selected from further characterization by focusing on their expression levels of progenitor markers and late hepatocyte makers. When the expression of Pou5f1/Oct4 and Dlk was analyzed, we found that most iHP clones expressed these two primitive endoderm and hepatic lineage (Fig. 4C) . Furthermore, mature hepatocyte markers Alb and ApoB exhibited very low expression levels in almost all iHP clones, but were highly expressed in LC14d and Hepa1-6 cell lines ( Fig. 4D and 4E ). Taken together, our results suggest that the clones iHP13-6, iHP13-19, iHP14-2 and iHP14-19 may represent hepatic progenitor cells.
Functional characterization of representative iHP clones
Based on the expression patterns of early progenitor markers and mature hepatocyte genes, five representative iHP clones (i.e., iHP13-6, iHP13-16, iHP13-19, iHP14-2, and iHP14-19) were selected for further functional characterizations. Morphologically, the five clones look similar although iHP14-2 adapted more fibroblast-like morphology (Fig. 5A) . We further assessed the endogenous expression patterns of hepatic/pancreatic transcription factors in the selected iHP clones. The results indicated that HNF3α/Foxa1, HNF3β/Foxa2, and HNF4α/MODY1 genes were expressed at varied levels in the iHP clones, as well as in LC14d hepatocytes (Fig. 5B) .
We next examined how the iHP cells responded to dexamethasone (Dex)-induced differentiation. When the iHP cells were treated with Dex (0.1 μM) for up to 10 days, the expression levels of AFP was found increased to varied degrees in all five iHP clones with the iHP13-16 exhibited the largest increase (Fig. 5C, top panel) . When the expression of late hepatocyte marker TAT was examined, all iHP clones except iHP14-2 exhibited significant increases (p<0.05) (Fig. 5C ). Taken together, the AFP and TAT expression results indicate that four of the five iHP clones are responsive to Dex-induced differentiation.
Since Indocyanine Green (ICG) uptake and glycogen storage are liver-specific functions associated with differentiated hepatocytes in vitro [85] , we examined whether the iHP clones had these capabilities upon Dex-induced differentiation. In the ICG uptake assay, we found that, although all clones exhibited some background ICG uptake, a significant increase in ICG uptake was observed in all five iHP clones while hepatoma Hepa1-6 cells did not exhibit any significant increase in ICG uptake upon Dex treatment (Fig. 5D , and data now shown). The glycogen storage capabilities were assessed by using the Periodic Acid-Schiff (PAS) staining. Upon Dex stimulation, all iHP clones exhibited varied levels of increase in PAS staining while the iHP13-16 and iHP14-2 clones were significantly stained at lower levels (Fig. 5E , and data not shown). Taken together, the above results indicate the selected five iHP clones retain the potential to undergo liver-specific terminal differentiation although there are discernable clonal variations in the differentiation efficiencies.
Cre-mediated reversal of immortalization reduces cell proliferative activity and improves hepatic differentiation of the iHP cells
As indicated in the SSR #69 vector (Fig. 3B) , the expression of SV40 T antigen in the iHP cells can be removed and thus may lead to the reversal of the immortalization process. We used a recombinant adenovirus expressing Cre recombinase (Ad-Cre) to transduce iHP cells, and the effective removal of SV40 T antigen was confirmed by Western blotting analysis using an SV40 T antibody (Fig. 6A) . When the SV40 T antigen was removed from the iHP cells, the Cre-expressing iHP cells grew at a significantly slower rate than that of the GFPexpressing iHP cells at all tested time points (p<0.05) (Fig. 6B) . As expected, the growth rate of the control Hepa1-6 cells was not affected. Thus, these results indicate that the SV40 T antigen-mediated immortalization of hepatic progenitor cells is reversible.
It has been reported a stable expression of SV40 T antigen may inhibit terminal differentiation of some cell types, such as skeletal muscle cells, myoblasts, and adipocytes [86] . We sought to test if the SV40 T antigen-mediated immortalization would inhibit the terminal differentiation of the iHP cells. Using the iHP14-19 cells transduced with Alb-GLuc reporter as an example, we found that the iHP14-19 cells were still able to differentiate (reflected by the increased Alb-GLuc activities) upon Dex stimulation in the presence of SV40 T antigen (p<0.05) (Fig. 6C) . We further found that Cre-mediated removal of SV40 T antigen led to increased Alb-GLuc activities of the iHP14-19 cells, compared with that of the Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry RNA was isolated at days 5 and 10, and subjected to qPCR analysis to detect the expression of AFP and TAT. All samples were normalized by GAPDH expression level. Fold of changes was calculated by dividing the qPCR expression values from the Dex treatment group by that from the respective DMSO control group. (D) Dex-induced Indocyanine Green (ICG) uptake assay. Subconfluent iHP cells were treated with Dex (0.1 μM) or DMSO for 10 days. Cells were washed with PBS and incubated with ICG (1mg/mL in complete DMEM) at 37°C for 1h, followed by PBS washes. ICG uptake was observed and recorded under bright field. Significantly lower ICG uptake in the DMSO treatment groups was detected (data not shown). Each assay condition was done in triplicate. Representative results are shown. (E) PAS staining for glycogen storage. Subconfluent iHP cells were treated with Dex (0.1 μM) or DMSO for 10 days. Cells were fixed with 4% paraformaldehyde, followed by stained with 0.5% periodic acid solution and the Schiff's reagent, and counterstained with hematoxylin. PAS staining was observed and recorded under bright field. Positive stainings are indicated by arrows. Significantly lower PAS staining in the DMSO treatment groups was observed (data not shown). Each assay condition was done in triplicate. Representative results are shown. Bi 
GFP-infected iHP control groups'. However, the removal of SV40 T antigen also increased the spontaneous differentiation of the iHP cells (Fig. 6C) . Nonetheless, the above results indicate that the immortalized phenotypes of the iHP cells can be effectively reversed by the introduction of Cre recombinase, and that SV40 T antigen-mediated immortalization exerts minimal inhibitory effect on terminal differentiation of the iHP cells.
The iHP cells are not tumorigenic in athymic nude mice SV40 T antigen can stimulate cell proliferation and may increase the risk of tumorigenesis in vivo [87] . We sought to test if the iHP cells had tendency to proliferate and form tumors in vivo, and if so whether the process can be reversed by Cre combinase. We first infected three iHP cells and control Hepa1-6 cells with Ad-Cre or Ad-GFP for 24h (Fig. 7A) . The transduced cells were harvested and subcutaneously injected into athymic nude mice. The animals were subjected to whole body live bioluminescence imaging using Xenogen IVIS 200 at day 1, week 1, and week 2 post cell implantation. At day 1, bioluminescence signal was readily detected in all injected animals, while the signal was found significantly decreased in the three iHP cell-injected animals at 1-week time point, and almost completely disappeared at 2-week time point (Fig. 7B) . On the contrary, the signal in the Hepa1-6 group progressively increased over the two week period (Fig. 7B) . As expected, Cre-transduced iHP cells yielded significantly lower signal than that of the GFP-transduced controls at as early as day 1 time point (p<0.05), while Hepa1-6 cells were not affected by Cre transduction (Fig. 7C) .
In addition to imaging, we continued to monitor the animals for up to 8 weeks and did not observe any tumor-like masses grown at the iHP cell injection sites. Taken together, these results demonstrate that the tested iHP cells are not tumorigenic, and that Cre-mediated removal of SV40 T antigen inhibits iHP cell proliferation in vivo.
Discussion
Although the true identity and features of liver stem cells remains to be fully understood, it is commonly accepted that hepatic progenitor cells are common progenitors of mature hepatocytes and biliary epithelial cells and act as the major component of the hepatic parenchyma in early liver development [40, 41, [88] [89] [90] . Thus, it is desirable to establish stable hepatic progenitor cells, which are non-tumorigenic and maintain the stem cell properties, as these cells provide a unique system to study stem cell regulation and to optimize conditions for directing endogenous regenerative potential towards a lineage-specific differentiation.
To overcome the limited life span of culturing primary hepatic progenitors, we established the reversibly immortalized hepatic progenitor (iHP) cells from mouse fetal liver tissues by stably expressing SV40 T antigen. A collection of individual iHP clones represents a repertoire of hepatic progenitor clones with varied differentiation potential. The iHP cells maintain long-term proliferative activity and express progenitor markers (Pou5f1/Oct4 and Dlk) and hepatocyte-related markers (HNF3 /Foxa1, HNF3β/Foxa2, and HNF4α/MODY1). Upon dexamethasone (Dex) stimulation, the iHP cells are able to express hepatocyte markers (AFP and TAT) and perform Indocyanine Green (ICG) -uptake and glycogen storage (PAS staining) functions. Cre recombinasemediated removal of SV40 T antigen reverses the proliferative activity of the iHP cells. When the iHP cells are subcutaneously implanted in the athymic nude mice, no tumor formation is observed for up to 8 weeks. Therefore, our results demonstrate that the established iHP cells are stable, reversible, and non-tumorigenic progenitor-like cells, which should be useful for studying liver stem cell biology, liver organogenesis and developing potential cell sources/ factors for hepatocyte transplantation therapy.
It has been widely reported that hepatocytes can be derived from embryonic stem cells, mesenchymal stem cells, and iPS cells [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] . While these progenitor/stem cells are potentially important sources for hepatocyte transplantation, the lineage-specificity and differentiation efficiency of these progenitor cells remain to be fully characterized in vivo. This matter is further complicated by our current lack of the knowledge and understanding of the detailed mechanism through which hepatic progenitors are regulated and directed to hepatocyte lineage-specific differentiation. Thus, liver progenitor cells isolated from both fetal and adult liver tissues should have the inherited advantages over those extrahepatic sources of stem cells [1, 21, [29] [30] [31] [32] [33] [34] [35] [36] .
Although it has been reported that relatively long-term culturing of liver progenitor cells can be achieved under special culture conditions [31, [37] [38] [39] , the primary progenitor cells usually have limited life span when maintained in vitro [40, 41] . Several earlier studies reported the generation of progenitor lines from liver. Bipotential cell lines (so-called palmate cell lines) were established from the liver tissues of transgenic mice expressing constitutively active human Met [91, 92] . Bipotential clonal cell lines in hepatocyte-enriched suspension culture were established from healthy liver of 8-10-week-old C57BL/6 mice [93] . Bipotential mouse embryonic liver (BMEL) cell lines were established from E14 embryos using Matrigel aggregate culture approach [30] . Stem-like cell lines were established from adult rat liver although the long-term culture nature of these lines were unclear [94] . Interestingly, longterm cultivation of subpopulations of non-parenchymal cells derived from non-injured livers were obtained using fetal liver cell-derived conditioned medium in the presence of the Rhoassociated kinase (ROCK) inhibitor Y-27632 [95] . Using the approach similar to what we reported here, epithelial liver stem cell lines were obtained from primate fetal liver tissues [96, 97] . Furthermore, it was reported that progenitor cells can be isolated from human adult livers using Thy-1 as a sorting marker and may be a potential candidate cell source for cell treatment in liver diseases [98] . Immortalization of primary cells has long been a practice for obtaining stable cell lines. The classical BALB/3T3 protocol proved the principle of cell immortalization [99] although this approach is not efficient and thus often replaced by the overexpression of oncogenes and/or the inactivation of tumor suppressor genes [100] . Many genes have been used to immortalize primary cells. The commonly-used oncogenes include telomerase (TERT), Kras, c-Myc, CDK4, cyclin D1, Bmi-1, and HPV 16 E6/E7, while the frequently inactivated tumor suppressor genes are p53, Rb, and p16
INK . Here, we employed SV40 T antigen, one of the most commonly used immortalization genes [101] , which plays essential roles in the infection of permissive cells, leading to production of progeny SV40 virions, and in the infection of nonpermissive cells, leading to malignant transformation [102, 103] . The ability of SV40 large T antigen to immortalize primary cells may be largely dependent on its ability to complex with p53 [104] . Using the reversible immortalization system expressing SV40 T antigen [49] , we have immortalized several types of progenitors and adult cells, including MEFs, mouse cardiomyogenic progenitor cells, mouse articular chondrocytes, stem cells of dental apical papilla, and mouse melanoblastic progenitor cells [50] [51] [52] [53] [54] . More recently, we demonstrate that piggyBac transposon-mediated stable expression of SV40 T antigen is a more efficient approach to the immortalizing primary cells [60] . The most noteworthy features shared by all of the SV40 T antigen-immortalized cells include that 1) they are reversible and become mortal upon the removal of SV40 T antigen from the immortalized cells; 2) stable expression of SV40 T antigen does not completely inhibit the differentiation potential although the removal of SV40 T antigen has been shown to improve the terminal differentiation; and 3) the immortalized cells are non-tumorigenic in immune compromised mice, even after an extended observation period [50] [51] [52] 54] .
In summary, we sought to overcome the mortality of primary hepatic progenitor cells in vitro, and established the reversibly immortalized hepatic progenitor (iHP) cells from mouse fetal liver tissues by stably expressing SV40 T antigen. More than 60 iHP clones were obtained. Among 32 clones were analyzed. We found the iHP cells maintain long-term proliferative activity and express progenitor markers and hepatocyte-related markers. Upon the induction of differentiation, the iHP cells are able to express mature hepatocyte markers and perform ICG uptake and glycogen storage functions. Removal of SV40 T antigen can reverse iHP cell proliferative activity. When the iHP cells were subcutaneously implanted in the athymic nude mice, no tumor formation is observed for up to 8 weeks. Therefore, our results demonstrate that the established iHP cells are stable, reversible, and nontumorigenic progenitor-like cells. The iHP cells should be a valuable resource for studying stem cell biology, liver organogenesis, hepatic tumorigenesis, and metabolic regulations, and identifying factors involved in directed lineage-specific differentiation for potential hepatocyte transplantation as a treatment of liver diseases.
